Cargando…
Guidelines on Vaccinations in Paediatric Haematology and Oncology Patients
Objective. Vaccinations are the most important tool to prevent infectious diseases. Chemotherapy-induced immune depression may impact the efficacy of vaccinations in children. Patients and Methods. A panel of experts of the supportive care working group of the Italian Association Paediatric Haematol...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020520/ https://www.ncbi.nlm.nih.gov/pubmed/24868544 http://dx.doi.org/10.1155/2014/707691 |
_version_ | 1782316080538058752 |
---|---|
author | Cesaro, Simone Giacchino, Mareva Fioredda, Francesca Barone, Angelica Battisti, Laura Bezzio, Stefania Frenos, Stefano De Santis, Raffaella Livadiotti, Susanna Marinello, Serena Zanazzo, Andrea Giulio Caselli, Désirée |
author_facet | Cesaro, Simone Giacchino, Mareva Fioredda, Francesca Barone, Angelica Battisti, Laura Bezzio, Stefania Frenos, Stefano De Santis, Raffaella Livadiotti, Susanna Marinello, Serena Zanazzo, Andrea Giulio Caselli, Désirée |
author_sort | Cesaro, Simone |
collection | PubMed |
description | Objective. Vaccinations are the most important tool to prevent infectious diseases. Chemotherapy-induced immune depression may impact the efficacy of vaccinations in children. Patients and Methods. A panel of experts of the supportive care working group of the Italian Association Paediatric Haematology Oncology (AIEOP) addressed this issue by guidelines on vaccinations in paediatric cancer patients. The literature published between 1980 and 2013 was reviewed. Results and Conclusion. During intensive chemotherapy, vaccination turned out to be effective for hepatitis A and B, whilst vaccinations with toxoid, protein subunits, or bacterial antigens should be postponed to the less intensive phases, to achieve an adequate immune response. Apart from varicella, the administration of live-attenuated-virus vaccines is not recommended during this phase. Family members should remain on recommended vaccination schedules, including toxoid, inactivated vaccine (also poliomyelitis), and live-attenuated vaccines (varicella, measles, mumps, and rubella). By the time of completion of chemotherapy, insufficient serum antibody levels for vaccine-preventable diseases have been reported, while immunological memory appears to be preserved. Once immunological recovery is completed, usually after 6 months, response to booster or vaccination is generally good and allows patients to be protected and also to contribute to herd immunity. |
format | Online Article Text |
id | pubmed-4020520 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-40205202014-05-27 Guidelines on Vaccinations in Paediatric Haematology and Oncology Patients Cesaro, Simone Giacchino, Mareva Fioredda, Francesca Barone, Angelica Battisti, Laura Bezzio, Stefania Frenos, Stefano De Santis, Raffaella Livadiotti, Susanna Marinello, Serena Zanazzo, Andrea Giulio Caselli, Désirée Biomed Res Int Review Article Objective. Vaccinations are the most important tool to prevent infectious diseases. Chemotherapy-induced immune depression may impact the efficacy of vaccinations in children. Patients and Methods. A panel of experts of the supportive care working group of the Italian Association Paediatric Haematology Oncology (AIEOP) addressed this issue by guidelines on vaccinations in paediatric cancer patients. The literature published between 1980 and 2013 was reviewed. Results and Conclusion. During intensive chemotherapy, vaccination turned out to be effective for hepatitis A and B, whilst vaccinations with toxoid, protein subunits, or bacterial antigens should be postponed to the less intensive phases, to achieve an adequate immune response. Apart from varicella, the administration of live-attenuated-virus vaccines is not recommended during this phase. Family members should remain on recommended vaccination schedules, including toxoid, inactivated vaccine (also poliomyelitis), and live-attenuated vaccines (varicella, measles, mumps, and rubella). By the time of completion of chemotherapy, insufficient serum antibody levels for vaccine-preventable diseases have been reported, while immunological memory appears to be preserved. Once immunological recovery is completed, usually after 6 months, response to booster or vaccination is generally good and allows patients to be protected and also to contribute to herd immunity. Hindawi Publishing Corporation 2014 2014-04-29 /pmc/articles/PMC4020520/ /pubmed/24868544 http://dx.doi.org/10.1155/2014/707691 Text en Copyright © 2014 Simone Cesaro et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Cesaro, Simone Giacchino, Mareva Fioredda, Francesca Barone, Angelica Battisti, Laura Bezzio, Stefania Frenos, Stefano De Santis, Raffaella Livadiotti, Susanna Marinello, Serena Zanazzo, Andrea Giulio Caselli, Désirée Guidelines on Vaccinations in Paediatric Haematology and Oncology Patients |
title | Guidelines on Vaccinations in Paediatric Haematology and Oncology Patients |
title_full | Guidelines on Vaccinations in Paediatric Haematology and Oncology Patients |
title_fullStr | Guidelines on Vaccinations in Paediatric Haematology and Oncology Patients |
title_full_unstemmed | Guidelines on Vaccinations in Paediatric Haematology and Oncology Patients |
title_short | Guidelines on Vaccinations in Paediatric Haematology and Oncology Patients |
title_sort | guidelines on vaccinations in paediatric haematology and oncology patients |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020520/ https://www.ncbi.nlm.nih.gov/pubmed/24868544 http://dx.doi.org/10.1155/2014/707691 |
work_keys_str_mv | AT cesarosimone guidelinesonvaccinationsinpaediatrichaematologyandoncologypatients AT giacchinomareva guidelinesonvaccinationsinpaediatrichaematologyandoncologypatients AT fioreddafrancesca guidelinesonvaccinationsinpaediatrichaematologyandoncologypatients AT baroneangelica guidelinesonvaccinationsinpaediatrichaematologyandoncologypatients AT battistilaura guidelinesonvaccinationsinpaediatrichaematologyandoncologypatients AT bezziostefania guidelinesonvaccinationsinpaediatrichaematologyandoncologypatients AT frenosstefano guidelinesonvaccinationsinpaediatrichaematologyandoncologypatients AT desantisraffaella guidelinesonvaccinationsinpaediatrichaematologyandoncologypatients AT livadiottisusanna guidelinesonvaccinationsinpaediatrichaematologyandoncologypatients AT marinelloserena guidelinesonvaccinationsinpaediatrichaematologyandoncologypatients AT zanazzoandreagiulio guidelinesonvaccinationsinpaediatrichaematologyandoncologypatients AT casellidesiree guidelinesonvaccinationsinpaediatrichaematologyandoncologypatients |